Erelzi and Cellulitis aggravated - a phase IV clinical study of FDA data

Summary:

Cellulitis aggravated is reported as a side effect among people who take Erelzi (etanercept-szzs), especially for people who are female, 50-59 old, have been taking the drug for 1 - 6 months also take Cimetidine, and have Complex regional pain syndrome.

The phase IV clinical study analyzes which people have Cellulitis aggravated when taking Erelzi. It is created by eHealthMe based on reports of 11,624 people who have side effects when taking Erelzi from the FDA, and is updated regularly.

What is Erelzi?

Erelzi has active ingredients of etanercept-szzs. eHealthMe is studying from 11,625 Erelzi users. Check the latest studies of Erelzi.

What is Cellulitis aggravated?

Cellulitis aggravated (worst condition of inaction under skin) is found to be associated with 1,545 drugs and 620 conditions by eHealthMe. Check the latest studies of Cellulitis aggravated.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

11,624 people reported to have side effects when taking Erelzi.
Among them, 180 people (1.55%) have Cellulitis aggravated.

Could Erelzi cause Cellulitis aggravated?

Among these 180 people:

How long have people been on Erelzi when they have Cellulitis aggravated? *

Click here to view more results

What is the gender of people who have Cellulitis aggravated when taking Erelzi? *

Click here to view

* Approximation only. Some reports may have incomplete information.

Do you take Erelzi and have Cellulitis aggravated?

- Check whether Cellulitis aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Erelzi:

Erelzi (11,625 reports)

Cellulitis aggravated treatments and more:

Cellulitis aggravated (10 reports)

How severe was Cellulitis aggravated and when was it recovered:

Cellulitis aggravated in Erelzi

Expand to all the drugs that have ingredients of etanercept-szzs:

Cellulitis aggravated and drugs with ingredients of etanercept-szzs

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Erelzi:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Cellulitis aggravated:

Cellulitis aggravated (1,545 drugs)

Browse all the conditions that are associated with Cellulitis aggravated:

Cellulitis aggravated (620 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on etanercept-szzs (the active ingredients of Erelzi) and Erelzi (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.